Charter Amendments
SEC 8-K Item 5.03 · articles, bylaws, fiscal year · renames flagged
no login
no paywall
no paywall
Which public companies changed their name, charter or bylaws this week? 39 companies filed SEC 8-K Item 5.03 (articles, bylaws or fiscal year) in the last 7 days, newest 30 Oct 2026, including Albemarle (ALB), Pelthos Therapeutics (PTHS), BioXcel Therapeutics, Us Bancorp \De\ (USB), Oxford Square Capital (OXSQ) and 34 more. Renamed, per the filer’s own header: Albemarle (ALB), formerly Echem; Pelthos Therapeutics (PTHS), formerly Channel Therapeutics; Us Bancorp \De\ (USB), formerly First Bank System; and 25 more. The board holds 383, each linked to SEC EDGAR.
Filer
Listing
Filed
Item
Doc
2026-10-30
—
Emerging growth company · FY2025 revenue $16.8M
formerly Channel Therapeutics Corp
“Castle Creek's late-stage fibroblast-based platform complements Pelthos' novel FDA-approved product portfolio and established commercial capabilities in dermatology.”
2026-10-30
—
“G. A reasonable opportunity to object and be heard with respect to the Sale, the Motion, and the relief requested therein has been afforded to all interested parties.”
2026-10-30
—
Large accelerated filer · FY2025 revenue $28.7B
formerly FIRST BANK SYSTEM INC
2026-10-30
—
Non-accelerated filer
formerly Oxford Street Capital Corp.
“Net investment income ("NII") was approximately $4.9 million, or $0.04 per share, for the quarter ended September 30, 2026, compared with approximately $5.1 million, or $0.05 per share, for the quarter ended June 30, 2026.”
2026-10-30
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $12.2M
formerly Banzai International, Inc.
2026-10-30
—
Non-accelerated filer · Smaller reporting company
formerly HARMONIC ENERGY, INC.
2026-10-30
—
AMERICAN REBEL HOLDINGS INC 🌊 Between
Non-accelerated filer · Smaller reporting company · FY2025 revenue $9.5M
formerly CUBESCAPE INC
“The work is a direct continuation of the initiative Champion announced September 23, when the company outlined plans to restructure the factory around lean manufacturing principles.”
2026-10-30
—
Emerging growth company · FY2025 revenue $81.8M
formerly EzFill Holdings Inc
“The Company's common stock will continue to trade on Nasdaq under the symbol "NXXT" and will begin trading on a split-adjusted basis when the market opens on October 30, 2026.”
2026-10-30
—
2026-10-30
—
2026-10-30
—
Large accelerated filer · FY2025 revenue $900.8M
2026-10-30
—
2026-10-29
—
2026-10-29
—
Accelerated filer · FY2025 revenue $879.3M
formerly DineEquity, Inc
“The Board adopted the Rights Agreement in response to media reports about a significant open market accumulation in Dine Brands’ stock and derivatives.”
2026-10-29
—
2026-10-29
—
Accelerated filer · Smaller reporting company · FY2026 revenue $381.3M
formerly TWIN DISC CLUTCH CO
2026-10-29
—
“A registration statement relating to these securities has been declared effective by the SEC.”
2026-10-28
—
Large accelerated filer · FY2025 revenue $20.1B
formerly Bank of New York Mellon CORP
2026-10-28
—
2026-10-28
—
Non-accelerated filer · Smaller reporting company
formerly ADial Pharmaceuticals, L.L.C.
“Azora has also launched a new corporate website at www.AzoraTherapeutics.com.”
2026-10-28
—
Non-accelerated filer · Smaller reporting company · FY2019 revenue $209K
formerly GlucoTrack, Inc.
“The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X and is presented for illustrative purposes only.”
2026-10-28
—
Large accelerated filer · FY2025 revenue $3.4B
formerly FIRST HORIZON NATIONAL CORP
2026-10-27
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $7.7M
formerly Securetech, Inc.
“15% Net Ownership Interest in Q STAK Holding, LLC Under a separate Stock Purchase Agreement, SecureTech acquired a net 15% ownership interest in QSTAK for $4.5 million, paid in newly issued shares of SecureTech’s Series A Preferred Stock rather than cash.”
2026-10-27
—
Non-accelerated filer · Smaller reporting company · Emerging growth company
formerly ATII Holdings Inc.
“ATII has elected not to present Management's Adjustments and will only be presenting Transaction Accounting Adjustments in the unaudited pro forma condensed combined financial information.”
2026-10-27
—
Large accelerated filer · FY2025 revenue $185.0B
“General Motors (NYSE: GM) today announced that it will transfer the listing of its common stock, par value $0.01 per share (the “Common Stock”), to the Nasdaq Global Select Market (“Nasdaq”) from the New York Stock Exchange (“NYSE”).”
2026-10-27
—
Large accelerated filer · FY2025 revenue $1.1B
“In March 2026, our Board approved an increase to Manhattan's share repurchase authority from $100 million to $500 million.”
2026-10-27
—
Large accelerated filer · FY2026 revenue $1.2B
formerly Madison Square Garden Sports Corp.
“The unaudited pro forma consolidated financial information has been derived from the Registrant’s historical consolidated financial statements and reflects certain assumptions and adjustments that management believes are reasonable under the circumstances and given the information available at this time.”
2026-10-27
—
formerly Anzu Special Acquisition Corp I
“About the Esteem Fully Implanted Active Middle Ear Implant (FI-AMEI) The Esteem fully implanted active middle ear implant (FI-AMEI) is the only FDA-approved, fully implanted* hearing device for adults diagnosed with moderate to severe sensorineural hearing loss allowing for 24/7 hearing capability using the ear's natural anatomy.”
2026-10-27
—
Emerging growth company · FY2025 revenue $13.9M
“Healthcare Triangle, Inc. (Nasdaq: HCTI ) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that it will effect a 1-for-20 reverse stock split of its common stock.”
2026-10-27
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $190K
2026-10-27
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $134.3M
formerly Hydrofarm Holdings Group, Inc.
2026-10-27
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $593K
formerly Trovagene, Inc.
“Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company targeting RAS-mutated cancer by leveraging PLK1 inhibition, today announced the appointment of Leila Alland, MD, as interim Chief Medical Officer.”
2026-10-27
—
2026-10-26
—
2026-10-26
—
Non-accelerated filer · Smaller reporting company · Emerging growth company
2026-10-26
—
Non-accelerated filer · Smaller reporting company · FY2022 revenue $5.0M
formerly AIxCrypto Holdings, Inc.
“Mr. Jia will continue to serve as the Chief Executive Officer of Faraday Future and Mr. Wang will continue to serve as the Global Executive Chairman of Faraday Future.”
2026-10-26
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $99.4M
2026-10-26
—
FY2025 revenue $239.0M
“Serving over 40,000 customer locations, Weave was named a 2026 Best Software Awards winner for healthcare software products by G2.”
2026-10-26
—
Emerging growth company · FY2025 revenue $50.4M
2026-10-26
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $60.5M
2026-10-23
—
Large accelerated filer · FY2025 revenue $2.9B
2026-10-23
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $8.3M
formerly CHF Solutions, Inc.
2026-10-23
—
Emerging growth company · FY2025 revenue $7.7M
formerly Bolt Therapeutics, Inc.
“Bolt Biotherapeutics, Inc. (Nasdaq: BOLT) (“Bolt” or the “Company”) today announced the acquisition of Prana Therapies, Inc. (“Prana”), a clinical-stage biotechnology company pioneering next-generation half-life-extended multispecific antibodies designed to deliver best-in-disease therapies.”
2026-10-23
—
Large accelerated filer · FY2025 revenue $113.1B
formerly BANKAMERICA CORP/DE/
2026-10-23
—
Emerging growth company · FY2025 revenue $1.9M
“RESOLVED, that Xiying (Thea) Zhang is appointed as a Director of the Company effective October 19, 2026.”
2026-10-23
—
Emerging growth company · FY2025 revenue $161.3M
“The Company and its Board of Directors engaged Piper Sandler to thoroughly evaluate a broad range of strategic and financing alternatives over the past 12 months with a singular focus on maximizing shareholder value.”
2026-10-23
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $947K
formerly BIO LAB NATURALS, INC.
2026-10-23
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $13.8M
formerly DIGITAL ALLY, INC.
2026-10-23
—
Large accelerated filer · FY2025 revenue $29.6B
2026-10-22
—
2026-10-22
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $21.5M
“A portion of the cash consideration came from the closing of the private placement announced on October 19, 2026.”
2026-10-22
—
formerly WELLS FARGO INCOME OPPORTUNITIES FUND
2026-10-22
—
formerly WELLS FARGO MULTI-SECTOR INCOME FUND
2026-10-22
—
formerly WELLS FARGO UTILITIES & HIGH INCOME FUND
2026-10-22
—
formerly WELLS FARGO GLOBAL DIVIDEND OPPORTUNITY FUND
2026-10-22
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $12.2M
formerly 7GC & Co. Holdings Inc.
“Shareholders approved both the corporate name change and reverse stock split at a special meeting of shareholders that was held on October 16, 2026.”
2026-10-22
—
2026-10-22
—
Emerging growth company · FY2025 revenue $4K
2026-10-22
—
Emerging growth company · FY2025 revenue $4.7M
2026-10-22
—
Emerging growth company · FY2025 revenue $38.6M
formerly BurTech Acquisition Corp.
“The Company’s Board of Directors has adopted resolutions providing that the Series B Preferred Stock will be uncertificated.”
2026-10-22
—
Large accelerated filer · FY2026 revenue $9.6B
formerly CACI INC /DE/
2026-10-21
—
Emerging growth company · FY2025 revenue $46.9M
formerly Capstone Therapeutics Corp.
“The Company’s Board of Directors approved the reverse stock split at the ratio of 1-for-30.”
2026-10-21
—
2026-10-21
—
Large accelerated filer · FY2025 revenue $8.8B
2026-10-20
—
Emerging growth company · FY2024 revenue $3.6M
formerly Asset Entities Inc.
“We have strategically adopted bitcoin as our hurdle rate for capital deployment because of our fiduciary duty to maximize long-term value for stockholders and compound purchasing power over time.”
2026-10-20
—
Emerging growth company
2026-10-20
—
Large accelerated filer · FY2025 revenue $2.4B
2026-10-20
—
Non-accelerated filer · Smaller reporting company · Emerging growth company
formerly SPAC III Acquisition Corp.
2026-10-20
—
2026-10-20
—
Non-accelerated filer · Smaller reporting company
“Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split of its common stock.”
2026-10-20
—
2026-10-20
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $10.4M
formerly Medalist Diversified REIT, Inc.
2026-10-19
—
Accelerated filer · FY2025 revenue $3.5B
formerly Conyers Park II Acquisition Corp.
2026-10-19
—
Large accelerated filer · FY2025 revenue $759.6M
2026-10-19
—
Non-accelerated filer · Smaller reporting company · Emerging growth company
“The registration statement relating to these securities has been declared effective by the Securities and Exchange Commission (the “SEC”) on October 15, 2026.”
2026-10-19
—
Emerging growth company · FY2025 revenue $68.5M
2026-10-19
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $44.5M
formerly MonoSol Rx, Inc.
2026-10-19
—
Non-accelerated filer · Smaller reporting company · FY2026 revenue $100K
formerly iBioPharma, Inc.
2026-10-19
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $17.4M
formerly Vivos BioTechnologies, Inc.
“Vivos Therapeutics, Inc. (Nasdaq: VVOS) ("Vivos" or the "Company") today announced that it has closed its acquisition of an 11% fully diluted equity interest in SOD Sciences, Inc. ("SOD Sciences" or "SOD") and a 50% undivided co-ownership interest in SOD's pseudohypoxia early-warning test, the "Primed Cell for Chronic Disease" test.”
2026-10-19
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $29.7M
formerly MECHANICAL TECHNOLOGY INC
2026-10-19
—
Large accelerated filer · FY2025 revenue $2.9B
formerly Atkore International Group Inc.
2026-10-19
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $741.7M
“The restructuring was completed on an accelerated timeline consistent with the Company's original expectations, and Cumulus continued to operate in the ordinary course throughout the process, with no disruption to operations, audiences, or advertisers.”
2026-10-16
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $16.4M
formerly VerifyMe, Inc.
2026-10-16
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $124K
formerly AMARILLO BIOSCIENCES INC
“A director elected to fill a vacancy shall be elected for the unexpired term of his predecessor in office.”
2026-10-16
—
AMAZE HOLDINGS, INC. 🍂 Fading
Emerging growth company · FY2025 revenue $2.0M
formerly Fresh Vine Wine, Inc.
2026-10-16
—
formerly MIDWEST GRAIN PRODUCTS INC
“MGP INGREDIENTS ANNOUNCES PLANS TO REBRAND AS SEMPREON New corporate identity will launch November 2, with planned Nasdaq ticker change to CASK, reflecting the company’s evolution across branded spirits, distilling and ingredient solutions ATCHISON, Kan.”
2026-10-15
—
Non-accelerated filer · Smaller reporting company · FY2026 revenue $4.8M
formerly UNIVERSAL SECURITY INSTRUMENTS INC
2026-10-15
—
Non-accelerated filer · Smaller reporting company · Emerging growth company
“Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today that it priced its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share.”
2026-10-15
—
Large accelerated filer · FY2025 revenue $266.0M
formerly INNOVATIVE GREENHOUSE PROPERTIES INC
2026-10-14
—
Emerging growth company · FY2025 revenue $95K
“Going Concern Uncertainty The Company's financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.”
2026-10-14
—
Accelerated filer · FY2025 revenue $1.6B
“Clear Channel Outdoor Holdings, Inc. ("Clear Channel" or the "Company"), a leader in U.S. out-of-home advertising, today announced the completion of its previously announced acquisition by Mubadala Capital.”
2026-10-14
—
Non-accelerated filer · Smaller reporting company · FY2021 revenue $13K
formerly Greater Cannabis Company, Inc.
2026-10-14
—
Non-accelerated filer · Smaller reporting company · Emerging growth company
2026-10-14
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $2.6M
formerly NanoVibronix, Inc.
2026-10-14
—
Accelerated filer · FY2025 revenue $300.8M
formerly Beauty Health Co
“At the Company’s Special Meeting of Stockholders held on September 22, 2026, stockholders approved a proposal authorizing a Reverse Stock Split with the exact ratio to be determined by the Board of Directors.”
2026-10-14
—
Large accelerated filer · FY2026 revenue $4.8B
formerly LOGITECH INTERNATIONAL SA
2026-10-13
—
Emerging growth company · FY2025 revenue $314.9M
“As previously announced, the Company’s Board has initiated a review of strategic alternatives to maximize stockholder value.”
2026-10-13
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $5K
formerly ZIOPHARM ONCOLOGY INC
2026-10-13
—
Emerging growth company · FY2025 revenue $11.5M
2026-10-13
—
“The closing follows the Company’s settlement of its senior secured debt and new working-capital financing, both completed in September.”
2026-10-13
—
LogicMark, Inc. 🌊 Between
Non-accelerated filer · Smaller reporting company · FY2025 revenue $11.4M
formerly Nxt-ID, Inc.
2026-10-13
—
Emerging growth company · FY2025 revenue $46.9M
formerly Capstone Therapeutics Corp.
2026-10-13
—
Emerging growth company · FY2025 revenue $4.9M
2026-10-13
—
INTELLIGENT BIO SOLUTIONS INC. ⚡ Not yet
Non-accelerated filer · Smaller reporting company · FY2026 revenue $4.2M
formerly GBS Inc.
2026-10-13
—
2026-10-13
—
Non-accelerated filer · Smaller reporting company
formerly Cortexyme, Inc.
“Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced that it has changed its name to IRulya Therapeutics Inc. effective at 4:01 p.m.”
2026-10-09
—
Emerging growth company · FY2025 revenue $9.7M
2026-10-09
—
“Management has determined that the results of operations of SPAC for the period from July 1, 2025 through July 17, 2025 were not material, and, accordingly, no separate adjustment has been reflected for such period.”
2026-10-09
—
Emerging growth company · FY2026 revenue $185.8M
2026-10-09
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $76.5M
2026-10-09
—
Emerging growth company · FY2025 revenue $41.4M
formerly GLOBAL HEALTHCARE REIT, INC.
2026-10-09
—
Non-accelerated filer · Smaller reporting company · Emerging growth company · FY2025 revenue $32K
2026-10-09
—
Emerging growth company · FY2025 revenue $78.6M
formerly PROOF Acquisition Corp I
2026-10-09
—
Non-accelerated filer · Smaller reporting company · FY2023 revenue $574K
formerly BISHOP EQUITIES INC
2026-10-09
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $130K
formerly AgeX Therapeutics, Inc.
2026-10-09
—
2026-10-08
—
Emerging growth company · FY2025 revenue $58.6M
formerly Chardan NexTech Acquisition 2 Corp.
2026-10-08
—
Blue Star Foods Corp. 🍂 Fading
Non-accelerated filer · Smaller reporting company · FY2025 revenue $2.9M
formerly AG ACQUISITION GROUP II, INC.
2026-10-08
—
Non-accelerated filer · Smaller reporting company · FY2022 revenue $7.7M
formerly PETROTERRA CORP.
2026-10-08
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $68K
formerly ADVANCED MEDICAL ISOTOPE Corp
2026-10-08
—
Emerging growth company · FY2025 revenue $164.9M
formerly Aurora Acquisition Corp.
2026-10-08
—
Non-accelerated filer · Smaller reporting company · FY2026 revenue $990K
formerly Marquie Group, Inc.
2026-10-08
—
2026-10-07
—
Non-accelerated filer · Smaller reporting company · FY2026 revenue $4.8M
formerly UNIVERSAL SECURITY INSTRUMENTS INC
“Universal DeFi's platform, which is currently accessible by invitation-only, has completed its first project, the tokenization of silver.”
2026-10-07
—
Accelerated filer · Smaller reporting company · FY2025 revenue $381.1M
formerly CAPITAL SENIOR LIVING CORP
2026-10-07
—
Emerging growth company
2026-10-07
—
Emerging growth company · FY2025 revenue $11.4M
formerly AquaMed Technologies, Inc.
2026-10-07
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $432K
formerly TRxADE HEALTH, INC
“The reverse stock split is expected to take effect before markets open on Monday, October 5, 2026.”
2026-10-07
—
Non-accelerated filer · Smaller reporting company · FY2026 revenue $990K
formerly Marquie Group, Inc.
2026-10-07
—
Non-accelerated filer · Smaller reporting company
formerly Angel Oak Mortgage, Inc.
2026-10-07
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $79.2M
formerly SIMULATIONS PLUS INC
“As previously announced, in connection with closing, Simulations Plus is being combined with Chemical Computing Group ("CCG"), an Altaris portfolio company and leading provider of molecular modeling and drug discovery software.”
2026-10-06
—
Non-accelerated filer · Smaller reporting company · Emerging growth company
formerly Renewal Fuels, Inc.
2026-10-06
—
Large accelerated filer · FY2024 revenue $29.2B
formerly New Pluto Global, Inc.
“Los Angeles, CA and New York, NY October 6, 2026 — Skydance Corporation (f/k/a Paramount Skydance Corporation) (NYSE: SKYD) ("Paramount") today announced the completion of its acquisition of Warner Bros.”
2026-10-06
—
Accelerated filer
“Granite Point Mortgage Trust Inc. (NYSE: GPMT) ("GPMT," "Granite Point" or the "Company") today announced the completion of its previously announced one-for-ten reverse stock split of the outstanding shares of the company's common stock (the "Reverse Stock Split").”
2026-10-06
—
Large accelerated filer · FY2025 revenue $96.2M
formerly BIOLIFE SOLUTION INC
2026-10-06
—
Large accelerated filer · FY2025 revenue $37.3B
formerly Discovery, Inc.
“Discovery, Inc., a Delaware corporation (the “Company”), adopted resolutions approving the ratification of certain potentially defective corporate acts, as described below, pursuant to Section 204 of the DGCL.”
2026-10-06
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $65K
formerly INOVIO BIOMEDICAL CORP
2026-10-06
—
2026-10-06
—
2026-10-06
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $109.2M
formerly Logical Choice Corp
2026-10-06
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $48.5M
formerly Novume Solutions, Inc.
2026-10-06
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $7.4M
formerly CIPHERLOC Corp
2026-10-06
—
Non-accelerated filer · Smaller reporting company · FY2024 revenue $1.0M
formerly VTV Therapeutics Inc.
2026-10-06
—
Non-accelerated filer · Smaller reporting company · FY2026 revenue $19.5M
formerly Oculus Innovative Sciences, Inc.
2026-10-06
—
Vivakor, Inc. ⚡ Not yet
Emerging growth company · FY2025 revenue $104.4M
“The Company’s Board of Directors approved a previous Reverse Stock Split at the ratio of 1-for-20, effective on July 17, 2026, and this Reverse Stock Split at the ratio of 1-for-15.”
2026-10-06
—
Large accelerated filer · FY2025 revenue $727.3M
formerly AMERICAN COMMUNICATIONS ENTERPRISES INC
“In conjunction with Mr. Zook being named Executive Chair, long-time Chair of the Board, Lynn Tetrault, will continue to serve as an independent director until the 2027 Annual Meeting of Stockholders, at which point she does not intend to stand for reelection.”
2026-10-05
—
Emerging growth company
“No assurance can be given that such offering will be completed on the terms described, or at all.”
2026-10-05
—
formerly Jaguar Animal Health, Inc.
“The ex-dividend date will be announced as soon as it is determined by the Nasdaq Stock Market.”
2026-10-05
—
Accelerated filer · Smaller reporting company · FY2026 revenue $182.6M
formerly LIFELINE THERAPEUTICS, INC.
2026-10-05
—
Emerging growth company · FY2025 revenue $10.7M
formerly Onfolio Holdings Inc
2026-10-05
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $13.8M
formerly DIGITAL ALLY, INC.
“On September 18, 2026, the Company's board of directors approved a 1-for-10 Reverse Stock Split.”
2026-10-05
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $68K
formerly ADVANCED MEDICAL ISOTOPE Corp
2026-10-05
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $424K
formerly METAWORKS PLATFORMS, INC.
2026-10-05
—
Large accelerated filer · FY2025 revenue $998.1M
2026-10-05
—
2026-10-02
—
Large accelerated filer · FY2024 revenue $3.9B
formerly Hub Group
“Michael Flannery, Peter McNitt, and Gary Yablon from the Company’s Board of Directors (the “ Board ”), amended and restated the bylaws of the Company with the Second Amended and Restated Bylaws, and appointed Messrs.”
2026-10-02
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $819K
formerly Ra Medical Systems, Inc.
2026-10-02
—
Non-accelerated filer · Smaller reporting company · FY2025 revenue $18.8M
formerly First America Resource Corp
2026-10-02
—
Non-accelerated filer · Smaller reporting company · FY2024 revenue $2.8M
formerly CEA Industries Inc.
2026-10-02
—
Non-accelerated filer · Smaller reporting company
formerly ContraVir Pharmaceuticals, Inc.
2026-10-02
—
formerly ChronoScale Corp
“New Infrastructure Agreements ChronoScale has signed a contract extension with an existing AI infrastructure customer and an agreement with a new AI infrastructure customer.”
2026-10-02
—
Non-accelerated filer · Smaller reporting company · FY2026 revenue $51.1M
formerly AMMO, INC.
2026-10-02
—
Emerging growth company
2026-10-02
—
Large accelerated filer · FY2025 revenue $67.5B
“The IBM (NYSE: IBM) board of directors has elected Frank Baker to the board, effective October 1, 2026.”
2026-10-01
—
2026-10-01
—
Large accelerated filer · FY2025 revenue $1.5B
formerly GENTHERM Inc
“Katrin Schatz will serve as the Interim President of Modine Performance Technologies, which will operate as a division of Gentherm.”
2026-10-01
—
Emerging growth company · FY2025 revenue $68.5M
“Under the transaction, the Company acquired latest-generation NVIDIA B300 GPUs, the high-performance processor at the core of modern AI data centers, and leased those assets back under a long-term lease, which is expected to generate recurring, long-term cash flows for the Company.”
2026-10-01
—
Emerging growth company · FY2025 revenue $252K
2026-10-01
—
Every row is a filing on SEC EDGAR and links to it. Item tags are the filer’s own. Nothing on this page is written or inferred — we undercount rather than guess.
Maintained by Jenny Huang Goodman MPA MSc MHSA, Principal · all boards · about
200 of 383 rows · newest first · all 383
This desk produces more than just great data. Halt the noise — dashboard.pops4.com — 30 seconds for your event needs, look better than your creators, keep your brand in the real.